By Mill Chart
Last update: May 13, 2025
ADAPTIVE BIOTECHNOLOGIES (NASDAQ:ADPT) has been identified by our stock screener as a high-growth momentum stock that also aligns with Mark Minervini’s Trend Template. The company, which focuses on immune medicine and diagnostics, shows strong technical and fundamental traits that could appeal to growth-oriented investors.
Minervini’s strategy emphasizes stocks in strong uptrends with clear technical strength. ADPT meets these criteria:
Beyond technicals, ADPT exhibits strong growth metrics:
According to ChartMill’s technical report, ADPT scores a perfect 10 on technical health, supported by strong short- and long-term trends. However, the setup rating of 3 suggests the stock may need a consolidation phase before offering an ideal entry point. Key support levels are at $7.20 and $6.65-$6.67.
Our High Growth Momentum + Trend Template screener lists more stocks with similar growth and trend characteristics.
This is not investment advice. The observations are based on current data, but investors should conduct their own research before making decisions.
9.51
+0.48 (+5.32%)
Find more stocks in the Stock Screener
ADAPTIVE BIOTECHNOLOGIES (ADPT) meets Minervini’s Trend Template with strong technicals and high growth momentum, making it a candidate for growth investors. The stock scores a perfect 10 on technical health but may need consolidation before an optimal entry.
Intrigued by the market activity one hour before the close of the markets on Friday? Uncover the key winners and losers of today's session in our insightful analysis.
Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session.
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.